Strategic Responses for the Airline Business During the Covid-19 Pandemic: A Review of Past Crises
ABAC Journal · 2023
DOI: 10.59865/abacj.2023.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift ABAC Journal, 2023. Verfasst von Thanavutd Chutiphongdech und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
This research article proposes strategic responses for airline businesses during the COVID-19 pandemic. Using a documentary method to review published academic journals and grey literature available in the online public domain, documents related to strategic responses from past crises in the airline industry were gathered and examined using content analysis. Well-recognized management consultant publications, and interview clips from airline management were also reviewed to extract lessons learned for formulating strategic responses to the COVID-19 crisis. This study found that government support, technological adoption, passenger-based collaboration, and airline management strategies are keywords underlying airline businesses’ strategic responses to withstand COVID-19. Managerial implications for airline management and industry stakeholders are presented at the end of the article.
Zitieren
APA
Chutiphongdech, T., Apiluckserbsakul, N., Choktanasukarn, K., & Phengkona, J. (2023). Strategic Responses for the Airline Business During the Covid-19 Pandemic: A Review of Past Crises. ABAC Journal. https://doi.org/10.59865/abacj.2023.26
Vancouver
Chutiphongdech T, Apiluckserbsakul N, Choktanasukarn K, Phengkona J. Strategic Responses for the Airline Business During the Covid-19 Pandemic: A Review of Past Crises. ABAC Journal. 2023. doi:10.59865/abacj.2023.26
BibTeX
@article{Chutiphongdech2023,
author = {Chutiphongdech, Thanavutd and Apiluckserbsakul, Nichakarn and Choktanasukarn, Kittipong and Phengkona, Jutamas},
title = {Strategic Responses for the Airline Business During the Covid-19 Pandemic: A Review of Past Crises},
journal = {ABAC Journal},
year = {2023},
doi = {10.59865/abacj.2023.26}
}
EUVIMED